Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2026

Equity [Abstract]

Schedule of Stock Option Activity

A summary of the Company’s stock option activity under the Plan for the three months ended March 31, 2026 is as follows:

	Number of Options	Weighted-Average Exercise Price		Weighted-Average Remaining Contract Life	Aggregate Intrinsic Value
				(in years)	(in thousands)
Outstanding at December 31, 2025	287,467	$	18.56	5.8	$	1,152
Exercised	(1,600)	18.86
Outstanding at March 31, 2026	285,867	$	18.56	5.6	$	2,675
Vested and expected to vest at March 31, 2026	285,867	$	18.56	5.6	$	2,675
Exercisable at March 31, 2026	285,867	$	18.56	5.6	$	2,675

Schedule of Unvested Restricted Stock Unit Activity

A summary of the Company’s unvested restricted stock units' activity under the Plan for the three months ended March 31, 2026 is as follows:

	Number of Shares Outstanding	Weighted Average Grant Date Fair Value
Unvested at December 31, 2025	43,500	$	28.53
Granted	84,000	22.34
Unvested at March 31, 2026	127,500	$	24.45